Liver resection versus non‐surgical treatment for hepatic node positive patients with colorectal metastases
References
Additional references
Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Annals of Surgical Oncology 2006;13(10):1271‐80.
Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five‐year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Annals of Surgical Oncology 2001;8(4):347‐53.
Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long‐term survival. Annals of Surgery 2004;240(4):644‐58.
Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Diseases of the Colon and Rectum 1999;42(5):632‐9.
Beckurts KT, Holscher AH, Thorban S, Bollschweiler E, Siewert JR. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. British Journal of Surgery 1997;84(8):1081‐4.
Bennett JJ, Cao D, Posner MC. Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases. Journal of Surgical Oncology 2005;92(1):64‐9.
Clark OA, Castro AA. Searching the Literatura Latino Americana e do Caribe em Ciencias da Saude (LILACS) database improves systematic reviews. International Journal of Epidemiology 2002;31(1):112‐4.
Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. The Oncologist 2003;8(6):553‐66.
DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50.
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88.
Egger M, Davey SG, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629‐34.
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first‐line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. Journal of Clinical Oncology 2007;25(13):1670‐6.
Gluud C, Als‐Nielsen B, D'Amico G, Fingerhut A, Gluud LL, Khan S, et al. Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2006, Issue 4. Art. No.: LIVER.
Gurusamy K, Imber C, Davidson BR. Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer ‐ a systematic review. http://www.hindawi.com/journals/hpb/raa.84150.html (accessed 20 August 2007).
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Intervention 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd, 2006.
Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. American Journal of Gastroenterology 2001;96(11):3178‐84.
Irie T, Itai Y, Hatsuse K, Mochizuki H. Does resection of small liver metastases from colorectal cancer improve survival of patients?. British Journal of Radiology 1999;72(855):246‐9.
Jaeck D, Nakano H, Bachellier P, Inoue K, Weber JC, Oussoultzoglou E, et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Annals of Surgical Oncology 2002;9(5):430‐8.
Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Annals of Surgical Oncology 2003;10(9):1007‐11.
Kemeny N, Jarnagin W, Paty P, Gonen M, Schwartz L, Morse M, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. Journal of Clinical Oncology 2005;23(22):4888‐96.
Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Journal of Clinical Oncology 2006;24(9):1395‐403.
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9.
Kokudo N, Seki M, Ohta H, Azekura K, Ueno M, Sato T, et al. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Annals of Surgical Oncology 1998;5(8):706‐12.
Laurent C, Sa CA, Rullier E, Smith D, Rullier A, Saric J. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. Journal of the American College of Surgeons 2004;198(6):884‐891.
Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine 2001;20(4):641‐54.
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Annals of Surgery 2006;244(2):254‐9.
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13.
Mutsaerts EL, van Ruth S, Zoetmulder FA, Rutgers EJ, Hart AA, van Coevorden F. Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10‐year single‐institute experience. Journal of Gastrointestinal Surgery 2005;9(2):178‐86.
Newell DJ. Intention‐to‐treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837‐41.
Onaitis MW, Noone RB, Hartwig M, Hurwitz H, Morse M, Jowell P, et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13‐year institutional experience. Annals of Surgery 2001;233(6):778‐85.
RevMan. Review Manager (RevMan). Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. British Journal of Surgery 2000;87(9):1142‐55.
Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.
Stipa F, Zernecke A, Moore HG, Minsky BD, Wong WD, Weiser M, et al. Residual Mesorectal Lymph Node Involvement Following Neoadjuvant Combined‐Modality Therapy: Rationale for Radical Resection?. Annals of Surgical Oncology 2004;11(2):187‐191.
Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data. Statistics in Medicine 2004;23(9):1351‐75.
Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. Journal of Clinical Oncology 2003;21(19):3623‐8.
Tocchi A, Mazzoni G, Brozzetti S, Miccini M, Cassini D, Bettelli E. Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. International Journal of Colorectal Disease 2004;19(6):580‐5.
Tsuchiya Y, Onda M, Sasajima K, Yamashita K, Nomura T, Makino H, et al. Effects of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma. Diseases of the Esophagus 2002;15(3):226‐231.
Vassiliou I, Arkadopoulos N, Theodosopoulos T, Fragulidis G, Marinis A, Kondi‐Paphiti A, et al. Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World Journal of Gastroenterology 2007;13(9):1431‐4.
Wood H, Rowan S, Quinn M, Cooper N. National Cancer Intelligence Centre, Office for National Statistics. Cancer incidence and mortality in the United Kingdom 2001‐03. http://www.statistics.gov.uk/downloads/theme_health/UK_inc&mort_final.xls 2005 (accessed on 05/03/06).
Yano M, Takachi K, Doki Y, Miyashiro I, Kishi K, Noura S, et al. Preoperative chemotherapy for clinically node‐positive patients with squamous cell carcinoma of the esophagus. Diseases of Esophagus 2006;19(3):158‐63.
